These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17101287)

  • 1. The oncogenic potential of growth hormone.
    Perry JK; Emerald BS; Mertani HC; Lobie PE
    Growth Horm IGF Res; 2006; 16(5-6):277-89. PubMed ID: 17101287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncogenic potential of autocrine human growth hormone in breast cancer.
    Waters MJ; Conway-Campbell BL
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):14992-3. PubMed ID: 15479760
    [No Abstract]   [Full Text] [Related]  

  • 3. Acromegaly and cancer.
    Jenkins PJ
    Horm Res; 2004; 62 Suppl 1():108-15. PubMed ID: 15761242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.
    Bielohuby M; Roemmler J; Manolopoulou J; Johnsen I; Sawitzky M; Schopohl J; Reincke M; Wolf E; Hoeflich A; Bidlingmaier M
    Exp Biol Med (Maywood); 2009 Aug; 234(8):1002-9. PubMed ID: 19491373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
    Ezzat S; Melmed S
    J Clin Endocrinol Metab; 1991 Feb; 72(2):245-9. PubMed ID: 1991795
    [No Abstract]   [Full Text] [Related]  

  • 6. Is breast cancer a potential side effect of GH treatment?
    De Leon DD; Donovan SM
    Nat Med; 1997 Oct; 3(10):1081-2. PubMed ID: 9334714
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical perspective: acromegaly and cancer: a problem.
    Jenkins PJ; Besser M
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2935-41. PubMed ID: 11443146
    [No Abstract]   [Full Text] [Related]  

  • 8. The neoplastic complications of acromegaly.
    Terzolo M; Daffara F; Reimondo G; Allasino B; Ventura M; Angeli A
    J Endocrinol Invest; 2003; 26(8 Suppl):32-4. PubMed ID: 15233209
    [No Abstract]   [Full Text] [Related]  

  • 9. A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intolerance.
    Iwakura H; Ariyasu H; Li Y; Kanamoto N; Bando M; Yamada G; Hosoda H; Hosoda K; Shimatsu A; Nakao K; Kangawa K; Akamizu T
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E802-11. PubMed ID: 19602582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less is more risky? Growth hormone and insulin-like growth factor 1 levels and cardiovascular risk.
    Maison P; Chanson P
    Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):650-1. PubMed ID: 17143307
    [No Abstract]   [Full Text] [Related]  

  • 12. [Growth hormone and bone].
    Salles JP
    Arch Pediatr; 2006 Jun; 13(6):666-8. PubMed ID: 16697612
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
    Devin JK; Young PP
    Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone physiology in health and disease: insights using genetic and transgenic models.
    Frohman LA
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():233-6. PubMed ID: 8887166
    [No Abstract]   [Full Text] [Related]  

  • 16. [Abnormal lipid metabolism in acromegaly].
    Inoue T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():162-6. PubMed ID: 11347050
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid receptor: roles in cancer.
    Aranda A; Martínez-Iglesias O; Ruiz-Llorente L; García-Carpizo V; Zambrano A
    Trends Endocrinol Metab; 2009 Sep; 20(7):318-24. PubMed ID: 19716314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency.
    Dorshkind K; Horseman ND
    Endocr Rev; 2000 Jun; 21(3):292-312. PubMed ID: 10857555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone and insulin-like growth factors in fish: where we are and where to go.
    Reinecke M; Björnsson BT; Dickhoff WW; McCormick SD; Navarro I; Power DM; Gutiérrez J
    Gen Comp Endocrinol; 2005 May; 142(1-2):20-4. PubMed ID: 15862544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.